CEO and Executive Director
International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
Leading the Future of HEOR
Nancy Berg became a transformational leader quite early in her career. She was the youngest person ever to head a global engineering/technical organization when she was named the Executive Director of the Society of Manufacturing Engineers (SME). But she decided to refocus her career toward healthcare after her husband, Tim Jackson, successfully battled non-Hodgkin’s lymphoma in 2009. Nancy developed an appreciation for the role that not only medical professionals, but healthcare research plays in the lives of patients and their caregivers. So she transformed her own career to lead organizations in the healthcare sector.
Nancy is now CEO and Executive Director of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), one of the leading global scientific and educational organizations for health economics and outcomes research (HEOR). Along with the Board of Directors, Nancy has designed and implemented a new Strategic Plan, Mission, and Vision (ispor.org/mission.asp) to guide the Society into the future, which recently celebrated its 20-year anniversary.
Under her leadership, both global membership and revenues have continually expanded. In the past year alone, more than 18,000 people from over 90 countries attended the Society’s leading global conferences. But ISPOR is so much more than the educational offerings it provides at scientific meetings. The society also develops research tools and other products to further advance scientific excellence in HEOR that are freely available on the society’s website. Examples include ISPOR’s Good Practices for Outcomes Research Reports, Global Health Care System Roadmaps, and International Digest of Databases.
Prior to joining ISPOR, Nancy was responsible for transformational change at the International Society for Pharmaceutical Engineering (ISPE). She was instrumental in creating synergies between pharmaceutical industry stakeholders to work on issues of shared concern. For instance, Nancy was influential in developing ISPE’s collaboration with the FDA on a Drug Shortages Initiative in which teams of ISPE members conducted innovative research that was ultimately cited by the FDA in its Strategic Plan and in Congressional testimony.
Nancy has also made her impact felt in the healthcare industry outside of work. She serves as a hospital volunteer in intensive care units and is a supporter of the Leukemia and Lymphoma Society’s Team in Training Program cycling events.